ATE276995T1 - Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren - Google Patents

Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren

Info

Publication number
ATE276995T1
ATE276995T1 AT01924700T AT01924700T ATE276995T1 AT E276995 T1 ATE276995 T1 AT E276995T1 AT 01924700 T AT01924700 T AT 01924700T AT 01924700 T AT01924700 T AT 01924700T AT E276995 T1 ATE276995 T1 AT E276995T1
Authority
AT
Austria
Prior art keywords
estrogen receptor
receptor modulators
selective estrogen
triphenylethylene derivatives
halogenated
Prior art date
Application number
AT01924700T
Other languages
English (en)
Inventor
Robert F Kaltenbach Iii
George L Trainor
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Application granted granted Critical
Publication of ATE276995T1 publication Critical patent/ATE276995T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AT01924700T 2000-04-05 2001-04-05 Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren ATE276995T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19457900P 2000-04-05 2000-04-05
PCT/US2001/011080 WO2001077057A2 (en) 2000-04-05 2001-04-05 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators

Publications (1)

Publication Number Publication Date
ATE276995T1 true ATE276995T1 (de) 2004-10-15

Family

ID=22718125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01924700T ATE276995T1 (de) 2000-04-05 2001-04-05 Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren

Country Status (8)

Country Link
US (1) US6528681B2 (de)
EP (1) EP1268389B1 (de)
JP (1) JP2004517033A (de)
AT (1) ATE276995T1 (de)
AU (1) AU2001251330A1 (de)
CA (1) CA2403144A1 (de)
DE (1) DE60105785D1 (de)
WO (1) WO2001077057A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6180731A (ja) * 1984-09-28 1986-04-24 Toshiba Corp 管球の製造方法
EP1417169A2 (de) 2001-08-11 2004-05-12 Bristol-Myers Squibb Pharma Company Selektive östrogenrezeptormodulatoren
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
EP1692127B1 (de) 2003-10-08 2008-07-02 Smithkline Beecham Corporation Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors
US7196119B2 (en) * 2003-10-21 2007-03-27 The Regents Of The University Of California Development of new selective estrogen receptor modulators
WO2009149081A1 (en) * 2008-06-02 2009-12-10 Novelmed Therapeutics, Inc. Method for treating inflammatory conditions
EP3205648A1 (de) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Östrogenrezeptormodulatoren und verwendungen davon
US8853423B2 (en) 2010-06-17 2014-10-07 Seragon Pharmaceuticals, Inc. Indane estrogen receptor modulators and uses thereof
GB2483736B (en) * 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
EP2791132A4 (de) 2011-12-14 2015-08-05 Seragon Pharmaceuticals Inc Östrogenrezeptormodulatoren und verwendungen davon
US9499538B2 (en) * 2012-03-20 2016-11-22 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
CN105121413B (zh) * 2013-03-14 2018-09-14 赛拉根医药股份有限公司 多环雌激素受体调节剂及其用途
CA2971216A1 (en) 2014-12-23 2016-06-30 The Regents Of The University Of California Methods for immunomodulation of cancer and infectious disease therapy
US12441745B2 (en) 2019-02-12 2025-10-14 Radius Pharmaceuticals, Inc. Processes and compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681835A (en) 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
AR008155A1 (es) * 1996-09-06 1999-12-09 Smithkline Beecham Corp Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
CN1275911A (zh) 1997-08-15 2000-12-06 杜克大学 一种预防或治疗雌激素依赖性疾病及失调的方法

Also Published As

Publication number Publication date
EP1268389A2 (de) 2003-01-02
JP2004517033A (ja) 2004-06-10
DE60105785D1 (de) 2004-10-28
WO2001077057A3 (en) 2002-06-13
AU2001251330A1 (en) 2001-10-23
US20020013297A1 (en) 2002-01-31
WO2001077057A2 (en) 2001-10-18
US6528681B2 (en) 2003-03-04
EP1268389B1 (de) 2004-09-22
CA2403144A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
WO2003016270A3 (en) Selective estrogen receptor modulators
DE60105785D1 (de) Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren
DK1353672T3 (da) Syntese af 4-amino-thalidomidenantiomerer
IL145941A0 (en) Compositions and methods for cancer treatment by selectively inhibiting vegf
TW200736196A (en) 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
ATE315033T1 (de) Subtituierte isoxazole derivate als estrogen rezeptor modulatore
MXPA04003439A (es) Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
EA200600048A1 (ru) Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
WO2002057261A3 (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
GEP20115213B (en) Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
IL139956A0 (en) Conformationally constrained backbone cyclized somatostatin analogs
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
AU2003288644A1 (en) Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
EA201190086A1 (ru) Сочлененные производные имидазола в качестве антагониста trpv3
ATE457308T1 (de) Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
GB0425548D0 (en) Radiolabelled ligands
DK1406902T3 (da) Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander
WO2004089313A3 (en) Novel olanzapine forms and related methods of treatment
DE60220179D1 (de) Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta
DK1455781T3 (da) Anvendelse af anastrozol til behandling af post-menopausale kvinder, der har tidlig brystkræft
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
TR200401601T4 (tr) Seçici estrojen reseptörü modülatörleri olarak trifeniletilen türevlerinin özel tuz biçimleri

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties